Latest News

  • COVID-19 News: NIST Shares Synthetic Virus For Test Validation, Published Results of Retesting, More

    Diagnostics World News | New COVID-19 risk model developed by Cleveland Clinic and published findings from a retesting study. Plus, symptom trackers deployed by colleges for Back to School and quantified synthetic virus fragments available from NIST.

    Aug 14, 2020
  • PacBio, Asuragen Collaborate on Carrier Screening Assays

    Diagnostics World News | Pacific Biosciences and Asuragen have launched a clinical research collaboration aimed at developing molecular assays based on PacBio’s Single Molecule, Real-Time (SMRT) Sequencing technology.

    Aug 11, 2020
  • The Long Game On Telehealth

    Diagnostics World News | As the pandemic has dragged on, medical practices everywhere have also started thinking seriously about how to better fit telehealth into their patient care workflow over the long term.

    Aug 11, 2020
  • FDA Approves First COVID-19 Serology Tests, Other News

    Diagnostics World News | In a report in the Journal of Molecular Diagnostics, researchers describe a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples. Elsewhere, the U.S. Food and Drug Administration has authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood. This, plus more, is included in this week’s COVID-19 news and research in the diagnostics industry.

    Aug 7, 2020
  • Next Generation Dx Summit Goes Virtual Offering Even More Content, Opportunities

    Diagnostics World NewsThe Next Generation Dx Summit is going virtual later this month, offering a rich content experience with even more opportunity to learn through on demand sessions, live panel discussions, and plenty of digital networking events including a robust exhibit hall.

    Aug 6, 2020
  • Follow the Money: Pan-Cancer Liquid Biopsy Investments, CBC from Finger-Stick Blood

    Diagnostics World News | Big investments in liquid biopsy this month, with $257M for a pan-cancer test from Thrive Earlier Detection and another $72M for complete blood count analysis from finger-stick blood. COVID-19 gets diagnostics funding too, pushing toward six million daily tests.

    Aug 5, 2020
  • MUSC Stretching ICU Surge Capacity To Statewide Proportions

    Diagnostics World News | The Medical University of South Carolina is trying to quickly stand up a telemedicine system to increase ICU surge capacity across the state during the ongoing COVID-19 outbreak.

    Aug 4, 2020
  • Ancestry Launches NGS Tests With Family History Component

    Diagnostics World News | Ancestry has launched AncestryHealth powered by Next Generation Sequencing. It is an upgrade to AncestryDNA + Traits, adding genetic health risk reports, a family health history tool, and other resources.

    Aug 4, 2020
  • European Diagnostics Market In Flux During, After COVID-19

    Diagnostics World News | In June, the Economist Intelligence Unit released an overview of the European in vitro diagnostics market pre- and post-COVID-19.

    Aug 3, 2020